A Study of Mosliciguat in PH-ILD
NCT: NCT06635850 · ACTIVE_NOT_RECRUITING
NCT IDNCT06635850
StatusACTIVE_NOT_RECRUITING
Start Date2024-10-29
Completion2028-01
SponsorPulmovant, Inc. (INDUSTRY)
First posted
Last updated
Brief Summary
This is a Phase 2, randomized, double-blind, placebo-controlled, multi-center clinical study to evaluate the safety and efficacy of inhaled mosliciguat in participants with pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Frequently Asked Questions
What is A Study of Mosliciguat in PH-ILD?
A Study of Mosliciguat in PH-ILD is a clinical trial registered under NCT06635850. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06635850?
The current status of NCT06635850 (A Study of Mosliciguat in PH-ILD) is: ACTIVE_NOT_RECRUITING.
When did A Study of Mosliciguat in PH-ILD start?
A Study of Mosliciguat in PH-ILD started on 2024-10-29.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.